These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21333751)
1. Fe3O4 nanoparticles with daunorubicin induce apoptosis through caspase 8-PARP pathway and inhibit K562 leukemia cell-induced tumor growth in vivo. Zhang G; Lai BB; Zhou YY; Chen BA; Wang XM; Lu Q; Chen YH Nanomedicine; 2011 Oct; 7(5):595-603. PubMed ID: 21333751 [TBL] [Abstract][Full Text] [Related]
2. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. Chen B; Cheng J; Wu Y; Gao F; Xu W; Shen H; Ding J; Gao C; Sun Q; Sun X; Cheng H; Li G; Chen W; Chen N; Liu L; Li X; Wang X Int J Nanomedicine; 2009; 4():73-8. PubMed ID: 19421372 [TBL] [Abstract][Full Text] [Related]
3. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway. Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961 [TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine. Wu YN; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):60-4. PubMed ID: 19236748 [TBL] [Abstract][Full Text] [Related]
5. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514 [TBL] [Abstract][Full Text] [Related]
6. Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy. Lai BB; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):345-51. PubMed ID: 19379564 [TBL] [Abstract][Full Text] [Related]
7. Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation. Bao W; Liu R; Xia G; Wang F; Chen B Drug Des Devel Ther; 2019; 13():1107-1115. PubMed ID: 31040647 [TBL] [Abstract][Full Text] [Related]
8. Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. Ren Y; Zhang H; Chen B; Cheng J; Cai X; Liu R; Xia G; Wu W; Wang S; Ding J; Gao C; Wang J; Bao W; Wang L; Tian L; Song H; Wang X Int J Nanomedicine; 2012; 7():2261-9. PubMed ID: 22619560 [TBL] [Abstract][Full Text] [Related]
9. Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells. Chen B; Cheng J; Shen M; Gao F; Xu W; Shen H; Ding J; Gao C; Sun Q; Sun X; Cheng H; Li G; Chen W; Chen N; Liu L; Li X; Wang X Int J Nanomedicine; 2009; 4():65-71. PubMed ID: 19421371 [TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cells. Chen B; Liang Y; Wu W; Cheng J; Xia G; Gao F; Ding J; Gao C; Shao Z; Li G; Chen W; Xu W; Sun X; Liu L; Li X; Wang X Int J Nanomedicine; 2009; 4():251-9. PubMed ID: 20011242 [TBL] [Abstract][Full Text] [Related]
11. Effects of magnetic nanoparticle of fe(3)o(4) and 5-bromotetrandrine on apoptosis of K562/A02 leukemic cells induced by daunorubicin. Shen MF; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):54-9. PubMed ID: 19236747 [TBL] [Abstract][Full Text] [Related]
12. Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo. Chen BA; Lai BB; Cheng J; Xia GH; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Xu CR; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM Int J Nanomedicine; 2009; 4():201-8. PubMed ID: 19918366 [TBL] [Abstract][Full Text] [Related]
13. Daunorubicin-TiO2 nanocomposites as a "smart" pH-responsive drug delivery system. Zhang H; Wang C; Chen B; Wang X Int J Nanomedicine; 2012; 7():235-42. PubMed ID: 22275838 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles. Wang J; Chen B; Chen J; Cai X; Xia G; Liu R; Chen P; Zhang Y; Wang X Int J Nanomedicine; 2011; 6():203-11. PubMed ID: 21445276 [TBL] [Abstract][Full Text] [Related]
16. The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance. Wang X; Zhang R; Wu C; Dai Y; Song M; Gutmann S; Gao F; Lv G; Li J; Li X; Guan Z; Fu D; Chen B J Biomed Mater Res A; 2007 Mar; 80(4):852-60. PubMed ID: 17072850 [TBL] [Abstract][Full Text] [Related]
17. [Combined effect of recombinant mutant human TRAIL and daunorubicin in inducing apoptosis of leukemia cell and its mechanism]. Zhang XJ; Wen L; Wang FX; Luo JM; Pan L; Liu XJ; DU XY; Dong ZR; Yang SF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1123-8. PubMed ID: 17204177 [TBL] [Abstract][Full Text] [Related]
18. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. Stiewe T; Parssanedjad K; Esche H; Opalka B; PĆ¼tzer BM Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674 [TBL] [Abstract][Full Text] [Related]
19. Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment. Guo D; Xu P; Chen D; Wang L; Zhu Y; Zuo Y; Chen B Int J Nanomedicine; 2020; 15():521-536. PubMed ID: 32021192 [TBL] [Abstract][Full Text] [Related]
20. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity]. Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]